Teikoku Pharma USA, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$222Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
10clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $37K
2020 $30K
2021 $33K
2022 $30K
2023 $29K
2024 $21K
2025 $41K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Clinical Genetics (M.D.) $115K
Pain Medicine (Anesthesiology) $55K
Rheumatology $26K
Hospice and Palliative Medicine (Internal Medicine) $19K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
John Cronin Woodside, CA Clinical Genetics (M.D.) $115,225.00
David Clark Palo Alto, CA Pain Medicine (Anesthesiology) $54,650.00
Lee Simon Boston, MA Rheumatology $25,618.25
Joseph Arthur Houston, TX Hospice and Palliative Medicine (Internal Medicine) $18,845.93
Akhila Reddy Houston, TX $7,247.55

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.